Ferozsons Laboratories Limited (PSX:FEROZ)

Market Cap	18.18B
Revenue (ttm)	18.16B
Net Income (ttm)	753.65M
Shares Out	43.47M
EPS (ttm)	17.34
PE Ratio	24.12
Forward PE	n/a
Dividend	3.00 (0.72%)
Ex-Dividend Date	Oct 18, 2024

Volume	30,827
Average Volume	96,256
Open	419.97
Previous Close	422.35
Day's Range	417.50 - 428.00
52-Week Range	242.33 - 464.00
Beta	0.33
RSI	50.62
Earnings Date	Sep 1, 2025

About Ferozsons Laboratories

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally. The company offers products in various therapeutic areas of anti-fungal, anti-viral, antibiotics, cardiometabolic, cough, dermatology, diabetes, gastrointestinal and liver, oncology, orthopedic, and urology and nephrology areas. It also provides medical devices in t...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1954
• Employees: 1,896
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: FEROZ

Financial Performance

In 2024, Ferozsons Laboratories's revenue was 15.85 billion, an increase of 38.38% compared to the previous year's 11.46 billion. Earnings were 683.15 million, an increase of 151.83%.